It appears legit "big" money is not interested in dealing with this company, they probably don't like the toxic deals, Management credibility/experience or current business plan and missed target dates. Also if Merck was really interested to expedite AE37 they would have financed the clinical trial or at least finalized recruitment!! Management has done a great job to keep the company alive but failed to execute accordingly. Adjustments imo necessary to attract "real" institutional participation and Analysts coverage. How about a PR with current valuation. Any target date for the 10k?? I'm sure it will take a few Q's to establish some revenue ............... our products represent billion dollar industries as stated in several PR's .......but unable to capitalize a few %.